Endocrinopathies in women during opioid therapy cause loss of androgens, fatigue, listlessness, loss of libido and quality of life: stop prescribing opioids or follow the 2016 Centers for Disease Control and Prevention guidelines?

Pain. 2017 Jan;158(1):1-3. doi: 10.1097/j.pain.0000000000000745.

Authors

Harald Breivik^{1

2

3}, Audun Stubhaug^{1

3}

Affiliations

¹ Department of Pain Management and Research, Oslo University Hospital, Norway.
² Department of Anesthesiology, Oslo University Hospital, Norway.
³ Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.

PMID: 27780180
DOI: 10.1097/j.pain.0000000000000745

No abstract available

Publication types

Comment

MeSH terms

Analgesics, Opioid / therapeutic use*
Androgens*
Centers for Disease Control and Prevention, U.S.
Female
Humans
Libido
Quality of Life

Substances

Analgesics, Opioid
Androgens